Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression.
Saved in:
| Title: | Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression. |
|---|---|
| Authors: | Holý P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Hlaváč V; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Šeborová K; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Šůsová S; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Tesařová T; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Rob L; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Hruda M; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Bouda J; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Bartáková A; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Mrhalová M; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Kopečková K; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Al Obeed Allah M; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Špaček J; University Hospital Hradec Králové, Hradec Kralove, Czech Republic., Sedláková I; University Hospital Hradec Králové, Hradec Kralove, Czech Republic., Souček P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Václavíková R; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. |
| Source: | International journal of cancer [Int J Cancer] 2024 Jul 01; Vol. 155 (1), pp. 104-116. Date of Electronic Publication: 2024 Mar 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
